Molecular Mechanisms and Potential Therapeutic Targets in Incisional Hernia

被引:15
|
作者
Thankam, Finosh G. [1 ,2 ]
Palanikumar, Gunasekar [1 ,2 ]
Fitzgibbons, Robert J. [1 ,2 ]
Agrawal, Devendra K. [1 ,2 ]
机构
[1] Creighton Univ, Sch Med, Dept Clin & Translat Sci, CRISS 2 Room 510,2500 Calif Plaza, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Surg, Omaha, NE 68178 USA
基金
美国国家卫生研究院;
关键词
Incisional hernia; Collagen phenotypes; Myofibroblasts; TGF-beta; 1; signaling; Matrix homeostasis; MARROW-DERIVED CELLS; TISSUE GROWTH-FACTOR; MYOFIBROBLAST DIFFERENTIATION; LATENT TGF-BETA-1; WOUND FAILURE; TGF-BETA; FIBROBLAST; REPAIR; FIBROCYTES; TENSION;
D O I
10.1016/j.jss.2018.11.037
中图分类号
R61 [外科手术学];
学科分类号
摘要
The pathophysiology underlying the formation, progression, and surgical healing of incisional hernia (IH) that develops as a major complication associated with abdominal laparotomy is poorly understood. The proposed mechanisms include the switch of collagen phenotype and the proliferation of abnormal fibroblasts after surgery. The focus of this article was to critically review the cellular, biochemical, and potential molecular events associated with the development of IH. The disturbance in collagen homeostasis with alterations in the expression of collagen subtypes, including type 1, type 3, type 4, and type 5, and impairment in the transdifferentiation of fibroblasts to myofibroblasts are discussed. The phenotype switch of wound-repair fibroblasts results in mechanically compromised extracellular matrix that triggers the proliferation of abnormal fibroblasts. High-mobility group box 1 could be involved in wound progression, whereas signaling events mediated by tumor necrosis factor b1, connective tissue growth factor, lysyl oxidase, and hypoxia-inducible factor 1 play significant role in the wound healing response. Thus, the ratio of tumor necrosis factor beta 1: high-mobility group box 1 could be a critical determinant of the underlying pathology. Potential target sites for therapeutic intervention in the management of IH are recognized. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 143
页数:10
相关论文
共 50 条
  • [31] Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
    Anderson, Nora
    Borlak, Juergen
    [J]. PHARMACOLOGICAL REVIEWS, 2008, 60 (03) : 311 - 357
  • [32] Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
    Gualtierotti, Roberta
    Ruscica, Massimiliano
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [33] Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets
    Chakravarthy, Harshini
    Devanathan, Vasudharani
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2018, 66 (03) : 445 - 461
  • [34] Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment
    Scassellati, Catia
    Ciani, Miriam
    Galoforo, Antonio Carlo
    Zanardini, Roberta
    Bonvicini, Cristian
    Geroldi, Cristina
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2020, 186
  • [35] Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
    Teixeira, J. Pedro
    Barone, Sharon
    Zahedi, Kamyar
    Soleimani, Manoocher
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [36] Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets
    Harshini Chakravarthy
    Vasudharani Devanathan
    [J]. Journal of Molecular Neuroscience, 2018, 66 : 445 - 461
  • [37] Molecular mechanisms of atrial fibrillation. Potential role of microRNAs as new therapeutic targets and potential biomarkers
    Wakili, R.
    Clauss, S.
    Kaeaeb, S.
    [J]. HERZ, 2012, 37 (02) : 166 - 171
  • [38] Therapeutic potential of benfotiamine and its molecular targets
    Raj, V.
    Ojha, S.
    Howarth, F. C.
    Belur, P. D.
    Subramanya, S. B.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (10) : 3261 - 3273
  • [39] Molecular targets and therapeutic potential of baicalein: a review
    Munjal, Kavita
    Goel, Yash
    Gauttam, Vinod Kumar
    Chopra, Hitesh
    Singla, Madhav
    Smriti
    Gupta, Saurabh
    Sharma, Rohit
    [J]. DRUG TARGET INSIGHTS, 2024, 18 : 30 - 46
  • [40] Molecular basis of β thalassemia and potential therapeutic targets
    Thein, Swee Lay
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2018, 70 : 54 - 65